Gut microbiota-mediated berberine metabolism ameliorates cholestatic liver disease by suppressing 5-hydroxytryptamine production

Dianji Tu(Army Medical University), Shiming Yang(State Council of the People's Republic of China), Yusong Ge(Army Medical University), Jiyin Zhou(Army Medical University), Hua Diao(Army Medical University), Jincheng Jian(Army Medical University), Hongfei Jiang(Qingdao University), Yingjie Wang(Shenyang Pharmaceutical University), Junfeng Guo(Shanghai Jiao Tong University), Xin Li(Harbin Medical University), Qiao Chen(Tianjin Medical University), Lulu Cheng(Army Medical University), Xiaojie Feng(Army Medical University), Lei Ran(Harbin Institute of Technology), Yuanyuan Lei(Army Medical University), Zhengguo Xu(Army Medical University), Yunxuan Feng(Tsinghua University), Yuanyuan Zhou(Army Medical University), Lu Cheng(Army Medical University)
Clinical and Molecular Hepatology
October 15, 2025
Cited by 6


Related Papers